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1 mg) were given at 08.00 hours on the morning of recording on nine occasions.
Results
(1) There was considerable variation of plasma testosterone levels during sleep (Fig 1) . A decline was usual with sleep onset, and subsequently fluctuations in testosterone level produced an overall increase and culminated in the morning peak.
(2) Fluctuations were found to relate to sleep in three different ways: (a) A rise occurred at the onset of REM sleep periods. (b) Frequently the rise preceded the periods of REM sleep. (c) Occasionally periods of arousal during the night were associated with a rise in testosterone level.
(3) Sleep reversal: In one subject, fluctuations in plasma testosterone (Fig 2) accompanied sleep in the day on three occasions. The usual diurnal trend was therefore reversed.
(4) While soluble ACTH had no effect on sleep or testosterone profiles when given at 08.00 hours, Synacthen 1 mg severely depressed REM sleep and promoted wakefulness during the night. Fluctuations in plasma testosterone were minimal and there was no overall rise.
(5) At a late point in the experiment, periods of intensive sampling (interval less than 5 min) showed marked fluctuations in plasma testosterone forming a series of peaks. Thirty-minute sampling was found to exert an overall 'smoothing' function on the testosterone profile. 1000 1100 1200 1300 1100 1500 1600 1700 1000 (Klein et al. 1966 , Permutt et al. 1966 , Beardwell & Wright 1968 , Miller & Moses 1969 . However, because of the low circulating levels of this hormone, and the presence in plasma and urine of substances producing nonspecific inhibition of antigen-antibody binding (Robertson et al. 1970 ), these immunoassays have not yet been generally applied to the measurement of plasma and urinary vasopressin in man. The development of a satisfactory extraction procedure has overcome some of these problems (Edwards et al. 1970 , Ratcliffe & Edwards 1970 Lysine-vasopressin has only 0 05 % and 0-06 % of the activity of AVP using these two antisera. Advantage can be taken of these differences in specificity in measuring one peptide analogue in the presence of another, and also in the identification of unknown analogues. We have, for example, measured the AVP and LVP content of two batches of Pitressin, the commercial preparation used for the treatment of diabetes inisipidus. This is prepared from bovine posterior pituitaries which contain AVP and porcine posterior pituitaries containing LVP. Of the two batches analysed one contained 55 % AVP and 45 % LVP, and the other 20 % AVP and 80 % LVP.
The iodination of vasopressin and the extraction procedure have been described elsewhere (Edwards et al. 1970 , Ratcliffe & Edwards 1970 ). Blood samples were taken into cooled heparinized syringes, and the plasma separated immediately in a refrigerated centrifuge. IN HCI 1 ml was added to each 5 ml plasma sample and the samples stored at -20°C before assay. Urine samples are acidified and stored in the same way.
MVeasurement of Vasopressin in Plasma
To validate the immunoassay and extraction procedure, the physiological and pharmacological release of vasopressin has been studied. Bioassay results suggest that the basal circulating level of AVP is 1-5 pg/ml plasma. The present minimal detectable level of the immunoassay is 10 pg/ml plasma and it is not yet possible to measure levels of circulating vasopressin in basal or dehydrated subjects.
(1) Physiological stimuli for the release of vasopressin: Serial samples from a feetal sheep subjected to hiemorrhage four days before term were assayed for vasopressin by immunoassay, and by bioassay by Dr Mary Forsling using the ethanol anesthetized rat (Forsling et al. 1968) . Fig 1  shows 
Conclusion
The use of radioimmunoassay for vasopressin, coupled with a simple extraction procedure for urine and plasma, provides a valuable tool for the investigation of physiological and pathological variations of this hormone. The results correlate well with those obtained by classical bioassays, while the procedure has a number of advantages over these in convenience and specificity.
